amphetamine and vitamin k 1

amphetamine has been researched along with vitamin k 1 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ginovart, N; Ibanez, V; Millet, P; Moulin-Sallanon, M; Steimer, T; Tournier, BB	1

Reviews

1 review(s) available for amphetamine and vitamin k 1

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for amphetamine and vitamin k 1

Article	Year
Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:11 Topics: Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Benzamides; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fluorodeoxyglucose F18; Gene Expression Regulation; Locomotion; Male; Nucleus Accumbens; Positron-Emission Tomography; Protein Binding; Psychotropic Drugs; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Tritium; Vitamin K 1	2012

Article

Year

Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:11

Topics: Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Benzamides; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fluorodeoxyglucose F18; Gene Expression Regulation; Locomotion; Male; Nucleus Accumbens; Positron-Emission Tomography; Protein Binding; Psychotropic Drugs; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Tritium; Vitamin K 1

2012